Jocelyn A Silvester International Celiac Disease Symposium 2026

Abstracts this author is presenting:

• Safety and Efficacy of TAK-101: Results from a Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Phase 2 Trial in Patients with Celiac Disease on a Gluten-Free Diet — Lunch & Elevated Poster Presentation Session 1